1. Academic Validation
  2. Raloxifene Prevents Chemically-Induced Ferroptotic Neuronal Death In Vitro and In Vivo

Raloxifene Prevents Chemically-Induced Ferroptotic Neuronal Death In Vitro and In Vivo

  • Mol Neurobiol. 2024 Oct 2. doi: 10.1007/s12035-024-04497-7.
Xiangyu Hao 1 Yifan Wang 1 Ming-Jie Hou 1 Lixi Liao 1 Yong Xiao Yang 1 Ying-Hua Wang 2 Bao Ting Zhu 3 4
Affiliations

Affiliations

  • 1 Shenzhen Key Laboratory of Steroid Drug Discovery and Development, School of Medicine, The Chinese University of Hong Kong (Shenzhen), 2001 Longxiang Road, Longgang District, Shenzhen, 518,172, China.
  • 2 Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • 3 Shenzhen Key Laboratory of Steroid Drug Discovery and Development, School of Medicine, The Chinese University of Hong Kong (Shenzhen), 2001 Longxiang Road, Longgang District, Shenzhen, 518,172, China. BTZhu@CUHK.edu.cn.
  • 4 Shenzhen Bay Laboratory, Shenzhen, 518,055, China. BTZhu@CUHK.edu.cn.
Abstract

Ferroptosis, a regulated form of cell death characterized by excessive iron-dependent lipid peroxidation, can be readily induced in cultured cells by chemicals such as erastin and RSL3. Protein disulfide isomerase (PDI) has been identified as an upstream mediator of chemically induced Ferroptosis and also a target for Ferroptosis protection. In this study, we discovered that raloxifene (RAL), a selective Estrogen receptor Modulator known for its neuroprotective actions in humans, can effectively inhibit PDI function and provide robust protection against chemically induced Ferroptosis in cultured HT22 neuronal cells. Specifically, RAL can bind directly to PDI both in vitro and in intact neuronal cells and inhibit its catalytic activity. Computational modeling analysis reveals that RAL can tightly bind to PDI through forming a hydrogen bond with its His256 residue, and biochemical analysis further shows that when PDI's His256 is mutated to Ala256, RAL loses its inhibition of PDI's catalytic activity. This inhibition of PDI by RAL significantly reduces the dimerization of both the inducible and neuronal nitric oxide synthases and the accumulation of nitric oxide, both of which have recently been shown to play a crucial role in mediating chemically induced Ferroptosis through subsequent induction of ROS and lipid-ROS accumulation. In vivo behavioral analysis shows that mice treated with RAL are strongly protected against kainic acid-induced memory deficits and hippocampal neuronal damage. In conclusion, this study demonstrates that RAL is a potent inhibitor of PDI and can effectively prevent chemically induced Ferroptosis in hippocampal neurons both in vitro and in vivo. These findings offer a novel estrogen receptor-independent mechanism for RAL's neuroprotective actions in animal models and humans.

Keywords

Ferroptosis; Nitric oxide; Nitric oxide synthase; Protein disulfide isomerase; Raloxifene; Reactive oxygen species; Selective estrogen receptor modulator.

Figures
Products